πŸ‡ΊπŸ‡Έ FDA
Patent

US 11839616

Ocular pharmaceutical compositions

granted A61KA61K31/53A61K9/0048

Quick answer

US patent 11839616 (Ocular pharmaceutical compositions) held by The Regents of the University of California expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/53, A61K9/0048, A61P, A61P27/02